A Novel Approach to Treating Anxiety and Enhancing Executive Skills in an Older Adult With Parkinson’s Disease

Abstract

Scientific interest in the nonmotoric symptoms of Parkinson’s disease (PD) has increased dramatically, and psychiatric symptoms (e.g., cognitive impairment, anxiety, and mood disorders) are now considered prime targets for treatment optimization. Psychiatric complications in PD are quite common, affecting as many as 60% to 80% of patients. This study describes the case of a 74-year-old male with PD who presented with complaints of anxiety and trouble with memory and attention. A combined cognitive behavior therapy (CBT) and cognitive enhancement intervention was delivered in ten 90-to-120 minute sessions.The patient showed a reduction in anxiety symptoms that was of sufficient magnitude to meet criteria for “responder” status. His cognitive skills were mostly unchanged, despite the rigorous rehabilitation practice. Implications for treatment and strategies for enhancing therapeutic benefits are discussed.

Keywords

Parkinson’s disease aging cognitive behavior therapy anxiety executive skills cognitive enhancement

Get full access to this article

View all access options for this article.

References

Alexopoulos, G.S. , Kiosses, D.N. , Klimstra, S. , & Kalayam, B. ( 2002). Clinical presentation of the "depression-executive dysfunction syndrome" of late life. American Journal of Geriatric Psychiatry , 10, 98-106.

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders - text revision (4th ed.). Washington, DC: Author.

Army Individual Test Battery. (1944). Manual of directions and scoring. Washington, DC: War Department, Adjutant General’s Office.

Barlow, D.H. ( 2002). Anxiety and its disorders: The nature and treatment of anxiety and panic (2nd ed.). New York: Guilford.

Basso, M.R. , Bornstein, R.A. , & Lang, J.M. ( 1999). Practice effects on commonly used measures of executive function across twelve months. Clinical Neuropsychologist , 13, 283-292.

Beck, A.T. , & Steer, R.A. ( 1987). Beck Depression Inventory: Manual. San Antonio, TX: Psychiatric Corporation.

Beck, A.T. , & Steer, R.A. ( 1990). Manual for the Beck Anxiety Inventory. San Antonio, TX: Psychological Corporation.

Benton, A.L. , & Hamsher, K. ( 1976). Multilingual aphasia examination (2nd ed.). Iowa City, IA: AJA Associates .

Burns, D.D. ( 2000). Feeling good: The new mood therapy. New York: Quill.

10.

Coelho, C.A. ( 2005). Direct attention training as a treatment for reading impairment in mild aphasia. Apahasiology, 19, 275-283.

11.

Cools, R. ( 2006). Dopaminergic modulation of cognitive function-Implications for L-dopa treatment in Parkinson’s disease. Neuroscience & Biobehavioral Reviews, 30, 1-23.

12.

Dennis, N.A. , & Cabeza, R. ( 2008). Neuroimaging of healthy cognitive aging. In F. I. M. Craik and T. A. Salthouse (Eds.) The handbook of aging and cognition (3rd ed., pp. 1-54). New York, NY: Psychology Press.

13.

Dobkin, R. , Allen, L. , & Menza, M. ( 2006). A cognitive behavioral package for depression in Parkinson’s Disease. Psychosomatics, 47, 259-263.

14.

Dreisig, H. , Beckmann, J. , Wermuth, L. , Skovlund, S. , & Bech, P. ( 1999). Psychologic effects of structured cognitive psychotherapy in young patients with Parkinson disease: A pilot study. Nordic Journal of Psychiatry, 53, 217-221.

15.

Ehrt, U. , & Aarsland, D. ( 2005). Psychiatric aspects of Parkinson’s disease. Current Opinions in Psychiatry, 18, 335-341.

16.

Feeney, F. , Egan. S. , & Gasson, N. ( 2005). Treatment of depression and anxiety in Parkinson’s disease: A pilot study using group cognitive behavioural therapy. Clinical Psychologist, 9, 31-38.

17.

Fenelon, G. , Mahieux, F. , Huon, R. , & Ziegler, M. ( 2000). Hallucinations in Parkinson’s disease: Prevalence, phenomenology and risk factors. Brain, 123, 733-745.

18.

First, M.B. , Gibbon, M. , Spitzer, R.L. , & Williams, J.B.W. (1995). Structured clinical interview for DSM-IV Axis I disorders. (version 2.0, October 1995, Final Version). New York: Biometrics Department, New York State Psychiatric Institute.

19.

Folstein, S.E. , Folstein, M.F. , & McHugh, P.R. (1975). "Mini-mental state": A practical method for grading the mental state of patients for the clinician . Journal of Psychiatric Research, 12, 189-198.

20.

Forsaa, E.B. , Larsen, J.P. , Wentzel-Larsen, T. , Herlofson, K. , & Alves, G. ( 2008). Predictors and course of health-related quality of life in Parkinson’s disease. Movement Disorders, 23, 1420-1427.

21.

Frazier, L.D. , Cotrell, V. , & Hooker, K. ( 2003). Possible selves and illness: A comparison of individuals with Parkinson’s disease, early-stage Alzheimer’s disease, and healthy older adults. International Journal of Behavioral Development, 27, 1-11.

22.

Fuster, J.M. ( 1997). The prefrontal cortex (3rd ed.). Philadelphia, PA: Lippincott-Raven . Goldman-Rakic, P.S. , Muly, E.C. III , & Williams , G.V. (2000). D1 receptor in prefrontal cells and circuits. Brain Research , 31, 295-301.

23.

Hamilton, M. ( 1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.

24.

Hamilton, M. ( 1960). A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry, 23, 56-62.

25.

Hariri, A.R. , Bookheimer, S.Y. , & Mazziotta, J.C. (2000). Modulating emotional responses: Effects of a neocortical network on the limbic system. NeuroReport , 11, 43-48.

26.

Higginson, C.I. , Fields, J.A. , Koller, W.C. , & Troster, A.I. ( 2001). Questionnaire assessment potentially overestimates anxiety in Parkinson’s Disease. Journal of Clinical Psychology in Medical Settings, 8, 95-99.

27.

Himadi, W.G. , Boyce, R. , & Barlow, D.H. ( 1986). Assessment of agoraphobia II: Measurement of clinical change. Behaviour Research & Therapy, 24, 321-332.

28.

Hoehn, M. , & Yahr, M. ( 1967). Parkinsonism: Onset, progression and mortality. Neurology, 17, 427-442.

29.

Kaplan, E.F. , Goodglass, H. , & Weintraub, H. ( 1983). The Boston naming test (2nd ed.). Philadelphia, PA : Lea & Febiger.

30.

Kinsella, K. , & Velkoff, V.A. ( 2001). An aging world: 2001. Washington, DC: U.S. Government Printing Office.

31.

Kulisevsky, J., Pagonabarraga, J., Pascual-Sedano, B., Garcia-Sanchez, C., Gironell A., & Trapecio Group Study. (2008). Prevalence and correlates of neuropsychiatric symptoms in Parkinson’s disease without dementia. Movement Disorders, 23, 1889-1896.

32.

Lauterbach, E.C. , Freeman, A. , & Vogel, R.L. ( 2003). Correlates of generalized anxiety and panic attacks in dystonia and Parkinson’s disease. Cognitive & Behavioral Neurology, 16, 225-233.

33.

Leroi, I. , Collins, D. , & Marsh, L. ( 2006). Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson’s disease: A review. Journal of Neurological Sciences, 248, 104-114.

34.

Levy, M.L. , & Cummings, J.L. (2000). Parkinson’s disease . In E. Lauterbach (Ed.), Psychiatric management in neurologic disease (pp. 41-70). Arlington, VA: American Psychiatric Publishing.

35.

Lezak, M.D. , Howieson, D.B. , Loring, D.W. , Hannay, H.J. , & Fischer, J.S. ( 2004). Neuropsychological assessment (4th ed.). New York: Oxford University Press.

36.

Lieberman, M.A. ( 2007). Psychological characteristics of people with Parkinson’s disease who prematurely drop out of professionally led Internet chat support groups. Cyber Psychology & Behavior, 10, 741-748.

37.

Mark, M.H. ( 2006). Pathogenesis, diagnosis, and treatment. In M. Menza & L. Marsh (Eds.), Psychiatric issues in Parkinson’s disease: A practical guide (pp. 1-17). London: Taylor & Francis.

38.

Marsh, L. ( 2000). Anxiety disorders in Parkinson’s disease. International Review of Psychiatry, 12, 307-318.

39.

Marsh, L. , Vaughan, C. , Schretlen, D. , Brandt, J. , & Mandir A.S. ( 2000). Psychomotor aspects of mood disorders in Parkinson’s disease. Biological Psychiatry, 47, 165S-165S.

40.

McCaffrey, R.J. , & Westerveldt, H.J. (1995). Issues associated with repeated neuropsychological assessments. Neuropsychology Review , 5, 203-221.

41.

McDougall, G.J. ( 2009). A framework for cognitive interventions targeting everyday memory performance and memory self-efficacy. Family and Community Health, 32, 515-526.

42.

McNamara, P. , Durso, R. , & Harris, E. ( 2006). Frontal lobe mediation of the sense of self: Evidence from studies of patients with Parkinson’s disease. In A. P. Prescott (Ed.), The concept of self in medicine health care (pp. 143-161). Hauppauge, NY: Nova Science Publishers.

43.

McQuinlan, A.D. , Licht, M.H. , & Licht, B.G. ( 2003). Contributions of disease severity and perceptions of primary and secondary control to the prediction of psychosocial adjustment to Parkinson’s disease. Health Psychology, 22, 504-512.

44.

Menza, M. , & Dobkin, R.D. ( 2005). Anxiety and Parkinson’s disease. Primary Psychiatry, 12, 30-34.

45.

Menza, M. , & Dobkin, R.D. ( 2006). Anxiety. In M. Menza & L. Marsh (Eds.), Psychiatric issues in Parkinson’s disease: A practical guide (pp. 139-153). New York: Taylor & Francis.

46.

Meyer, T.J. , Miller, M.L. , Metzger, R.L. , & Borkovec, T.D. (1990). Development and validity of the Penn State Worry Scale. Behaviour Research & Therapy , 28, 487-495.

47.

Mitte, K. , Noack, P. , Stell, R. , & Hautzinger, M. (2005). A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. Journal of Clinical Psychopharmacology, 25, 141-150.

48.

Mohlman, J. ( 2004). Psychosocial treatment of late life generalized anxiety disorder: Current status and future directions. Clinical Psychology Review, 24, 149-169.

49.

Mohlman, J. ( 2008). More power to the executive? CBT plus executive training for late life generalized anxiety disorder. Cognitive & Behavioral Practice, 15, 306-316.

50.

Mohlman, J. , Gorenstein, E.E. , Kleber, M.S. , de Jesus, M. , Gorman, J.M. , & Papp, L.A. ( 2003). Standard and enhanced cognitive behavior therapy for late life generalized anxiety disorder: Two pilot investigations. American Journal of Geriatric Psychiatry, 11, 24-32.

51.

Mohlman, J. , & Gorman, J.M. ( 2005). The role of executive functioning in CBT: A pilot study with anxious older adults. Behaviour Research & Therapy , 43, 447-465.

52.

Palmese, C.A. , & Raskin, S.A. ( 2000). The rehabilitation of attention in individuals with mild traumatic brain injury using the APT-II programme. Brain Injury , 14, 535-548.

53.

Pascual-Sedano, B. , Kulisevsky, J. , Barbanoj, M. , Garcia-Sanchez, C. , Campolongo, A. , Gironell, A. , et al. (2008). Levodopa and executive performance in Parkinson’s disease: A randomized study. Journal of the International Neuropsychological Society, 14, 832-841.

54.

Pero, S. , Incoccia, C. , Caracciolo, B. , Zoccolotti, P. , & Formisano, R. ( 2006). Rehabilitation of attention in two patients with traumatic brain injury by means of "attention process training." Brain Injury, 20, 1207-1219.

55.

Rektorova, I. , Rektor, I. , Bares, M. , Dostal, V. , Ehler, E. , Fiedler, J. , et al. (2003). Pramipexole and pergolide in the treatment of depression in Parkinson’s disease. International Journal of Geriatric Psychiatry, 10, 399-406.

56.

Richard, I.H. , Frank, S. , McDermott, M.P. , Wang, H. , Justus, A.W. , LaDonna, K.A. , et al. (2004). The ups and downs of Parkinson’s disease: A prospective study of mood and anxiety fluctuations. Cognitive & Behavioral Neurology, 17, 201-207.

57.

Riedel, O. , Klotsche, J. , Spottke, A. , Deuschl, G. , Forstl, H. , Henn, F. , et al. (2008). Cognitive impairment in 873 patients with idiopathic Parkinson’s disease. Journal of Neurology , 255, 255-264.

58.

Ryder, K.A. , Gontkovsky, S.T. , McSwan, K.L. , Scott, J.G. , Bharucha, K.J. , & Beatty, W.W. ( 2002). Cognitive function in Parkinson’s disease: Association with anxiety but not depression. Aging, Neuropsychology, & Cognition, 9, 77-84.

59.

Schrag, A. , & Jahanshahi, N.Q. (2004). What contributes to quality of life in patients with Parkinson’s disease? Journal of Neurology, Neurosurgery, & Psychiatry, 69, 308-331.

60.

Shear, M.K. , Vander Bilt, J. , Rucci, P. , Endicott, J. , Lydiard, B. , Otto, M.W. , et al. (2001). Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale. Depression & Anxiety, 13, 166-178.

61.

Shulman, L.M. , Taback, R.L. , Bean, J. , & Weiner, W.J. ( 2001). Comorbidity of the non-motor symptoms of Parkinson’s disease. Movement Disorders, 16, 507-510.

62.

Silverstein, S.M. , Hatashita-Wong, M. , Solar, B.A. , Uhlhaas, P. , Landa, Y. , Wilkness, S.M. , et al. (2005). Effectiveness of a two-phase cognitive rehabilitation intervention for severely impaired schizophrenia patients. Psychological Medicine, 35, 829-837.

63.

Sinforiani, E. , Banchieri, L. , Zucchella, C. , Pacchetti, C. , & Sandrini, G. ( 2004). Cognitive rehabilitation in Parkinson’s disease . Archives of Gerontology & Geriatrics, Suppl9, 387-391.

64.

Sohlberg, M.M. , Johnson, L. , Paule, L. , Raskin, S.A. , & Mateer, C.A. ( 2001). Attention process training-II. Wake Forest, NC: Lash & Associates.

65.

Sohlberg, M.M. , McLaughlin, K.A. , Pavese, A. , Heidrich, A. , & Posner, M.I. ( 2000). Evaluation of attention process training and brain injury education in persons with acquired brain injury. Journal of Clinical & Experimental Neuropsychology, 22, 656-676.

66.

Spear Bassett, S. ( 2006). Cognitive impairment. In M. Menza & L. Marsh (Eds.), Psychiatric issues in Parkinson’s disease: A practical guide (pp. 63-75). London : Taylor & Francis.

67.

Spielberger, C.D. , Gorsuch, R.L. , Lushene, P.R. , Vagg, P.R. , & Jacobs, A.G. ( 1983). Manual for the State-Trait Anxiety Inventory Test (Form Y). Palo Alto, CA: Consulting Psychological Press.

68.

Stanley, M.A. , Beck, J.G. , & Glassco, J.D. ( 1996). Treatment of generalized anxiety in older adults: A preliminary comparison of cognitive-behavioral and supportive approaches. Behavior Therapy, 27, 565-581.

69.

Stanley, M.A. , Beck, J.G. , Novy, D.M. , Averill, P.M. , Swann, A.C. , Diefenbach, G.J. , et al. (2003). Cognitive-behavioral treatment of late-life generalized anxiety disorder. Journal of Consulting & Clinical Psychology, 71, 309-319.

70.

Tariot, P.N. ( 2001). Maintaining cognitive function in Alzheimer’s disease . Alzheimer Disease and Associated Disorders, 15, S26-S33.

71.

Trenerry, M.R. , Crosson, B. , DeBoe, J. , & Leber, W.R. ( 1989). Stroop neuropsychological screening test manual. Odessa, FL: Psychological Assessment Resources.

72.

Thommessen, B. , Aarsland, D. , Braekhus, A. , Oksengaard, A.R. , Engedal, K. , & Laake, K. ( 2002). The psychosocial burden on spouses of the elderly with stroke, dementia, and Parkinson’s disease. International Journal of Geriatric Psychiatry, 17, 78-84.

73.

Troster, A.I. , Woods, S.P. , & Morgan, E.E. ( 2007). Assessing cognitive change in Parkinson’s disease: Development of practice effect = corrected reliable change indices. Archives of Clinical Neuropsychology, 22, 711-718.

74.

Walsh, K. , & Bennett, G. ( 2001). Parkinson’s disease and anxiety. Postgraduate Medicine Journal, 77, 89-93.

75.

Wechsler, D. ( 1997). Wechsler adult intelligence scale and Wechsler memory scale technical manual (3rd ed.). San Antonio, TX: Psychological Corporation.

76.

Weintraub, D. , & Stern, M.B. ( 2005). Psychiatric complications in Parkinson disease. American Journal of Geriatric Psychiatry, 13, 844-851.

77.

Wetherell, J.L. , Gatz, M. , & Craske, M.G. ( 2003). Treatment of generalized anxiety disorder in older adults . Journal of Consulting & Clinical Psychology, 71, 31-40.

78.

Williams, J.B.W. ( 1988). A structured interview guide for the Hamilton Depression Rating Scale. Archives of General Psychiatry, 45, 742-747.